Investigational PI3K/AKT/mTOR inhibitors in development for endometrial cancer

Barra, F; Evangelisti, G; Desideri, LF; Di Domenico, S; Ferraioli, D; Vellone, VG; De Cian, F; Ferrero, S

Ferrero, S (reprint author), IRCCS Osped Policlin San Martino, Acad Unit Obstet & Gynecol, Largo R Benzi 10, I-16132 Genoa, Italy.

EXPERT OPINION ON INVESTIGATIONAL DRUGS, 2019; 28 (2): 131

Abstract

Introduction: Endometrial cancer (EC) is the most common neoplasm of the female genital tract in developed countries. Despite the progress in early de......

Full Text Link